Brief: Mabion Accepts New $144,900 Order From Novavax
13/08/2026 15:13
BRIEF-Mabion Accepts New $144,900 Order From Novavax Aug 13 (Reuters) - Mabion SA MABP.WA:
ACCEPTS NEW ORDER FROM NOVAVAX FOR SPECIALIST ANALYTICAL SERVICES
TO CONDUCT STABILITY STUDIES FOR SARS-COV-2 VACCINE IN PRE-FILLED SYRINGES
NEW CONTRACT VALUED AT $144,900 TO BE EXECUTED IN Q4 2026
Source text: ID:nEMbcBGcZa
Further company coverage: MABP.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; 48 58 769 66 00;))
Recent news on Mabion SA
See all newsBrief: Mabion Partner Oddifact Says FDA Consultations Allow MabionCD20 To Be Used As First-Line Therapy For ITP
Brief: Mabion Holds Pre-IND Type B Meeting With FDA On MabionCD20 Development For ITP
Brief: Mabion Signs LoI With WPD Pharmaceuticals On Extension Of Cooperation
Brief: Mabion Q2 Net Loss At 15 Mln Zlotys
Brief: Mabion Signs Deal With Novavax Expanding Cooperation To Analytical Services For Early-Stage Pipeline Projects